Literature DB >> 17337470

Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.

Marlies E Kevenaar1, Axel P N Themmen, Joop S E Laven, Barbara Sonntag, Sharon Lie Fong, André G Uitterlinden, Frank H de Jong, Huibert A P Pols, Manuela Simoni, Jenny A Visser.   

Abstract

BACKGROUND: In mice, anti-Müllerian hormone (AMH) inhibits primordial follicle recruitment and decreases FSH sensitivity. Little is known about the role of AMH in human ovarian physiology. We hypothesize that in women AMH has a similar role in ovarian function as in mice and investigated this using a genetic approach.
METHODS: The association of the AMH Ile(49)Ser and the AMH type II receptor (AMHR2) -482 A > G polymorphisms with menstrual cycle characteristics was studied in a Dutch (n = 32) and a German (n = 21) cohort of normo-ovulatory women.
RESULTS: Carriers of the AMH Ser(49) allele had higher serum estradiol (E(2)) levels on menstrual cycle day 3 when compared with non-carriers in the Dutch cohort (P = 0.012) and in the combined Dutch and German cohort (P = 0.03). Carriers of the AMHR2 -482G allele also had higher follicular phase E(2) levels when compared with non-carriers in the Dutch cohort (P = 0.028), the German cohort (P = 0.048) and hence also the combined cohort (P = 0.012). Women carrying both AMH Ser(49) and AMHR2 -482G alleles had highest E(2) levels (P = 0.001). For both polymorphisms no association with serum AMH or FSH levels was observed.
CONCLUSIONS: Polymorphisms in the AMH and AMHR2 genes are associated with follicular phase E(2) levels, suggesting a role for AMH in the regulation of FSH sensitivity in the human ovary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337470     DOI: 10.1093/humrep/dem036

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

1.  The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH.

Authors:  Sandro Sacchi; Giovanni D'Ippolito; Paola Sena; Tiziana Marsella; Daniela Tagliasacchi; Elena Maggi; Cindy Argento; Alessandra Tirelli; Simone Giulini; Antonio La Marca
Journal:  J Assist Reprod Genet       Date:  2015-12-02       Impact factor: 3.412

2.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

3.  Anti-Mullerian hormone normogram in an Irish subfertile population.

Authors:  M N Naasan; C Harrity; L Pentony; E Mocanu
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

4.  Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan.

Authors:  Katherine S Ruth; Ana Luiza G Soares; Maria-Carolina Borges; A Heather Eliassen; Susan E Hankinson; Michael E Jones; Peter Kraft; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Jack A Taylor; Anne Zeleniuch-Jacquotte; Deborah A Lawlor; Anthony J Swerdlow; Anna Murray
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

5.  Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Gulum Kosova; Brian Werstein; Ryan Sisk; Richard S Legro; M Geoffrey Hayes; Jose M Teixeira; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

6.  Can polymorphisms of AMH/AMHR2 affect ovarian stimulation outcomes? A systematic review and meta-analysis.

Authors:  Di Chen; Xiangyu Zhu; Jielei Wu
Journal:  J Ovarian Res       Date:  2020-09-04       Impact factor: 4.234

7.  Possible involvement of single nucleotide polymorphisms in anti-Müllerian hormone signaling pathway in the pathogenesis of early OHSS in Han Chinese women.

Authors:  Lan Wang; Hemei Li; Jihui Ai; Hanwang Zhang; Yiqing Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

8.  Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Authors:  Daniel A Dumesic; Timothy G Lesnick; Jacques P Stassart; G David Ball; Ashley Wong; David H Abbott
Journal:  Fertil Steril       Date:  2009-07       Impact factor: 7.329

9.  Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.

Authors:  Meng-Xue Zheng; Yan Li; Rong Hu; Fei-Miao Wang; Xiao-Mei Zhang; Bing Guan
Journal:  J Assist Reprod Genet       Date:  2016-01-06       Impact factor: 3.412

10.  Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.

Authors:  Neoklis A Georgopoulos; Eleni Karagiannidou; Vasiliki Koika; Nikolaos D Roupas; Anastasia Armeni; Dimitra Marioli; Efstathios Papadakis; C K Welt; Dimitrios Panidis
Journal:  J Clin Endocrinol Metab       Date:  2013-08-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.